Samsung Medical Center (Samsung Comprehensive Cancer Center)

Samsung Medical Center (SMC) is a major academic medical centre in Irwon-dong, Gangnam-gu, Seoul, South Korea. Founded in 1994 by the Samsung Group and affiliated with the Sungkyunkwan University School of Medicine, it is widely recognised as one of the leading healthcare institutions in Asia and worldwide.

The Samsung Comprehensive Cancer Center (SCCC) is the largest dedicated cancer facility in Asia. The SCCC operates as a standalone comprehensive cancer hospital, with organ-specific tumour centres, a CAR-T Cell Therapy Center, a Proton Therapy Center, and a Precision Oncology Treatment Center.

It holds one of the largest genomic clinical databases in the world, applying next-generation sequencing (NGS) and a dedicated Molecular Tumour Board for refractory and relapsed cancers.

It is equipped with robotic surgery (da Vinci), Gamma Knife radiosurgery, pencil-beam proton therapy, and advanced nuclear medicine.

The on-site Proton Therapy Center uses pencil-beam scanning and respiratory gating to treat complex, moving tumours in the lung and liver while sparing healthy tissue.

Systemic cancer therapies: Delivers leading-edge precision chemotherapy, immunotherapy, targeted therapy, and cell therapy (such as CAR-T).

Precision oncology: Applies molecular diagnostics and comprehensive genomic analysis to map tumour biology and select a matched targeted therapy or gene-based trial.

Dedicated cancer centres: Disease-specific units covering brain tumours, breast cancer, colorectal cancer, stomach cancer, urological cancer, gynaecological cancer, head and neck cancer, haematological malignancies, and liver cancer.